Strategy of Neoadjuvant Therapy for Resectable/Borderline Resectable Pancreatic Cancer

被引：0
|
作者：
Hashimoto, D. [1 ]
Satoi, S. [1 ]
Yamamoto, T. [1 ]
Yamaki, S. [1 ]
Hirooka, S. [1 ]
Ishida, M. [1 ]
Ikeura, T. [1 ]
Sekimoto, M. [1 ]
机构：
[1] Kansai Med Univ, Hirataka, Japan
来源：
PANCREAS | 2021年 / 50卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1064 / 1064
页数：1
相关论文
共 50 条
  • [11] Neoadjuvant treatment of primarily resectable and borderline resectable pancreatic cancer
    Scheufele, F.
    Friess, H.
    CHIRURG, 2020, 91 (05): : 391 - 395
  • [12] Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
    Kovtun, K.
    Moser, J. A.
    Callery, M.
    Kent, T.
    Tseng, J.
    Miksad, R.
    Bullock, A.
    Schlechter, B.
    Mahadevan, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E198 - E198
  • [13] Updates on the Use of Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer
    Chandhok, Namrata Sonia
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2014, 15 (02): : 91 - 94
  • [14] Outcome Following Neoadjuvant Therapy for Borderline Resectable Pancreatic Cancer
    Stokes, J. B.
    Walters, D. M.
    Norris, N. J.
    Stelow, E. B.
    Rich, T. A.
    Weiss, G. R.
    De Lange, E. E.
    Adams, R. B.
    Bauer, T. W.
    ANNALS OF SURGICAL ONCOLOGY, 2009, 16 : 80 - 80
  • [15] Neoadjuvant therapy in resectable and borderline pancreatic adenocarcinomas
    Perez Casanova, L.
    Serrano, T.
    Fabregat, J.
    Valls, C.
    Laquente, B.
    Condom, E.
    VIRCHOWS ARCHIV, 2014, 465 : S311 - S311
  • [16] Adjuvant Therapy versus neoadjuvant Therapy for Borderline resectable Pancreatic Cancer
    Manekeller, Steffen
    ZENTRALBLATT FUR CHIRURGIE, 2018, 143 (05): : 457 - 457
  • [17] Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer
    Heinemann, V.
    Haas, M.
    Boeck, S.
    ANNALS OF ONCOLOGY, 2013, 24 (10) : 2484 - 2492
  • [18] Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
    Versteijne, Eva
    de Hingh, Ignace H. J. T.
    Homs, Marjolein Y. V.
    Intven, Martijn P. W.
    Klaase, Joost M.
    van Santvoort, Hjalmar C.
    de Vos-Geelen, Judith
    Wilmink, Johanna W.
    van Tienhoven, Geertjan
    FRONTIERS IN ONCOLOGY, 2022, 11
  • [19] Evidence and Future Perspectives for Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Scoping Review
    Endo, Yutaka
    Kitago, Minoru
    Kitagawa, Yuko
    CANCERS, 2024, 16 (09)
  • [20] Neoadjuvant Chemoradiation With Intensity Modulated Radiation Therapy in Resectable and Borderline Resectable Pancreatic Cancer (PCa)
    Kharofa, J. R.
    Kelly, T.
    Wood, C.
    George, B.
    Tsai, S.
    Ritch, P.
    Wiebe, L.
    Christians, K.
    Evans, D.
    Erickson, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S89 - S89
12345